May 2021, AcceXible, Spain

/in /by

May 2021, AcceXible, Spain, (https://www.accexible.com), announced that it is entering a collaboration agreement with pharmaceutical company Eli Lilly to pilot-test the company’s vocal bio-marker platform that is able to detect and monitor early-stage dementia and other cognitive impairments with accuracy levels of higher than 90%. AcceXible is already working with NHS in the UK and recently received an innovation award from the UK’s Department of International Trade.